analyst
PH
NASDAQ · PHAT
Phathom Pharmaceuticals, Inc.
Healthcare · Biotechnology
$7.36
Up+$0.01 (+0.14%)
Updated Sep 30, 2026, 3:40 AM
SID Score
3.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.04B
- P/E ratio
- -3.89
- Dividend yield
- 0.00%
- 52-week range
- $6.91 – $18.31
- Volume
- 657.26K
- Avg. volume
- 1.06M
Price performance · PHAT
PHAT price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Sep 29, 2026
PHAT closed at $7.36 after 20 trading sessions, down 21.62% for the selected period.
- Last close
- $7.36
- Period change
- -21.62%
- Period low
- $6.99
- Period high
- $9.50
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 29, 2026 | $7.34 | $7.45 | $7.185 | $7.36 | 657.26K |
| Sep 28, 2026 | $7.30 | $7.41 | $7.15 | $7.35 | 1.69M |
| Sep 25, 2026 | $7.10 | $7.38 | $7.095 | $7.30 | 1.44M |
| Sep 24, 2026 | $6.98 | $7.19 | $6.91 | $7.08 | 1.42M |
| Sep 23, 2026 | $7.825 | $7.825 | $6.98 | $6.985 | 1.05M |
| Sep 22, 2026 | $7.58 | $7.84 | $7.40 | $7.76 | 1.95M |
| Sep 21, 2026 | $7.54 | $7.62 | $7.31 | $7.45 | 898.88K |
| Sep 18, 2026 | $7.63 | $7.763 | $7.465 | $7.48 | 1.79M |
| Sep 17, 2026 | $7.81 | $8.00 | $7.59 | $7.75 | 1.5M |
| Sep 16, 2026 | $8.00 | $8.24 | $7.66 | $7.69 | 2.07M |
| Sep 15, 2026 | $8.63 | $8.655 | $8.10 | $8.16 | 1.64M |
| Sep 14, 2026 | $8.45 | $8.8299 | $8.35 | $8.68 | 1.32M |
| Sep 11, 2026 | $8.40 | $8.52 | $8.07 | $8.36 | 1.39M |
| Sep 10, 2026 | $8.50 | $8.545 | $8.29 | $8.37 | 1.09M |
| Sep 9, 2026 | $9.32 | $9.32 | $8.64 | $8.67 | 1.11M |
| Sep 8, 2026 | $9.42 | $9.65 | $9.22 | $9.43 | 1.03M |
| Sep 4, 2026 | $8.99 | $9.55 | $8.8901 | $9.50 | 1.24M |
| Sep 3, 2026 | $9.30 | $9.3113 | $8.984 | $9.05 | 663.06K |
| Sep 2, 2026 | $9.45 | $9.7296 | $9.05 | $9.26 | 932.65K |
| Sep 1, 2026 | $9.55 | $9.675 | $9.15 | $9.39 | 885.49K |
Latest PHAT news
The latest Smart Investors Daily articles mentioning PHAT.
Stock researchMarket Activity · Options
Company
OverviewForecastEarnings — requires Earnings Calls and Results accessDividend — requires Dividend Research accessFinancials
Market Activity
OptionsInsider Trades — requires Insider Buying and Selling accessShort InterestInstitutional Ownership — requires Institutional Ownership accessSentiment
Research & News
Loading stock research…